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Abstract
Background: Nutritional factors play a major role in cancer initiation and development. Dietary polyunsaturated
fatty acids (PUFAs) have the ability to induce modifications in the activity of lipoxygenase (LOX) and
cyclooxygenase (COX) enzymes that affect tumour growth. We studied the effect of two diets enriched in 6%
Walnut and Peanut oils that are rich in ω-3 and ω9 PUFAs respectively on a murine mammary gland
adenocarcinoma as compared with the control (C) that received commercial diet.
Results: Peanut oil enriched diet induced an increase in membrane arachidonic acid (AA) content and the
cyclooxygenase enzyme derived 12-HHT (p < 0.05) and simultaneously showed decrease in 12-LOX, 15-LOX-2,
15-LOX-1 and PGE activities (p < 0.05) that corresponded to higher apoptosis and lower mitosis seen in this group
(p < 0.05). Furthermore, Peanut oil group showed lower T-cell infiltration (p < 0.05), number of metastasis
(p < 0.05) and tumour volume (p < 0.05) and longer survival rate compared to other groups.
Conclusions: The results of the present study showed that Peanut oil-enriched diet protects against mammary
cancer development by modulating tumour membrane fatty acids composition and LOX and COX enzyme
activities.
Introduction
Epidemiological studies showed that breast cancer inci-
dence is increasing and is the third leading cause of
death due to cancer [1]. Of all the environmental fac-
tors, nutrition has a significant role in the initiation and
progression of breast cancer [2]. Dietary ω-3 and ω-6
polyunsaturated fatty acids (PUFAs) have been shown to
play an important role in human breast, colon, prostate,
pancreas, and stomach cancers [3]. Several studies sug-
gested that ω-3 and ω-6 PUFAs are cytotoxic to differ-
ent types of cancer cells and may act synergistically with
current chemotherapeutic drugs [4].
Arachidonic acid (20:4, ω-6, AA) derived from the
dietary essential fatty acid linoleic acid (18:2 ω-6, LA)
can induce apoptosis of tumor cells by its ability to con-
vert sphingomyelin to ceramide that triggers the release
of pro-apoptotic proteins [5]. In addition, AA is con-
verted by the catalytic activities of cyclooxygenase
(COX), lipoxygenase (LOX) and cytochrome P450
(CYP450) enzymes to several eicosanoids that have
potent biological actions [6]. Eicosanoids may act as
active carcinogens or tumour promoters in view of their
pro-inflammatory actions and by modulating the expres-
sion of various oncogenes and anti-oncogenes and thus,
participate in cancer development [7,8]. Hence, inhibi-
tion or modulation of the AA cascade may suppress
inflammatory events to bring about their anti-carcino-
genic effects. Tumour cell-derived PGE2 inhibit the pro-
duction of immune regulatory lymphokines, T-cell and
B cell proliferation, and the cytotoxic activity of natural
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manipulation of lipid sources may induce modification
of PUFAs composition and physical properties of cell
membranes that, in turn, influence eicosanoid synthesis
and thus, affect tumour growth. Hence, we studied the
effects of two dietary oils, one enriched in ω-3 and ω-6
from Walnuts and the other from Peanuts rich in ω-6
and ω-9 PUFAs on LOX and COX enzyme activities
and their influence on the growth of a murine mam-
mary gland adenocarcinoma and the results are reported
here.
Methods
Plant material, oil extraction and analysis
Walnut (Juglans regia L. var. Chandler) and Peanut
(Arachis hypogaea L., Runner market type) seeds were
obtained from local markets of Argentina. Oils were
extracted according to the procedure described by
Tobares et al. [10]
Tumour
Murine transplantable mammary adenocarcinoma (M3)
in weaning BALB/c mice was used in the present study.
M3 tumour is associated with 40% incidence of lung
metastasis with a latency period of 6 ± 2 days after
inoculation [11]. Three months after feeding the experi-
mental animals with Walnut and Peanut oils, mice were
inoculated with the tumour. Transplantation of tumours
and other animal studies were conducted in accordance
with the guidelines of the National Institutes of Health
(NIH) Guide for the Care and Use of Laboratory Ani-
mals and all the procedures were approved by the Ani-
mal Research Committee of the Institute of Oncology
A.H. Roffo, Buenos Aires, Argentina.
Diets, Feeding Protocol, M3 tumour inoculum, Tumour
Analysis
Three different isocaloric diets (caloric density 4,3 kcal/g)
were used. The control group was fed on a commercial
diet (GEPSA- Grupo Pilar, Argentina), considered as nor-
mal-fat diet (6% fat) for rodents containing ω-9: ω-6: ω-3
ratio = .1.4: 1.5: 0.1 The other two experimental groups
were fed on a basic semi-synthetic diet, adjusted to the
control diet in relation to nutrient content. The final
composition of the experimental diets were: 6% tested oil,
17% casein, 33% sucrose, 38% corn starch, 2% fiber, 2%
salt mixture and 0.5% vitamin mixture. The fatty acid
(FA) oil composition is shown in Table 1. Diet 1 = sup-
plemented with Walnut oil (Walnut) that has ω-9: ω-6:
ω-3 ratio = 0.7: 1.7: 0.6; while diet 2 was supplemented
with Peanut oil (Peanut) that has ω-9: ω-6: ω-3 ratio =
1.6: 1.4: 0.01.
Sixty post-weaned male and female BALB/c mice were
randomly distributed among three groups (20 mice
each). Food and water were provided ad libitum.A n i -
mals were kept in a light and temperature-controlled
room. After three months of feeding with respective
diets, mice were inoculated subcutaneously with 1 mm
3
of tumour tissue and were sacrificed 35 days after the
inoculation of the tumor. At the end of the study,
tumour volume was measured by a digital caliper and
tumour cell (TC) suspensions were isolated from pri-
mary tumours for further studies [12]. The number of
macroscopic metastasis was recorded in all the organs
of the three groups of animals with the aid of a magni-
fying lens.
Fatty acids analysis of oils and tumor cell membranes of
animals fed Walnut and Peanut oils
Both Walnut and Peanut oils were subjected to alkaline
saponification (1 N KOH) and the unsaponifiable matter
was extracted with n-hexane and fatty acid methyl esters
(FAME) were obtained using 1N sulfuric acid in metha-
nol [13].
Tumor cell plasma membrane purification was
achieved as described by Calderon et al [14]. Briefly,
tumor cells (1 × 10
6) were placed in homogenization
solution (hypotonic Hepes-Manitol buffer) (Sigma-
Aldrich, St. Louis, MO, USA) and homogenized using a
Polytron (7 s. at setting 7). The homogenate was treated
with 10 mM of CaCl2 and centrifuged at 3000 g for
15 min. The supernatant was saved and centrifuged at
48000 g for 30 min, and the pellet containing the
plasma membrane fragments, was collected in deionized
water and the lipids in the lower phase were extracted
with chloroform: methanol: H2O( 3 : 4 8 : 4 7v / v ) .F A M E s
were obtained with toluene and sodium metoxide at 4°C
overnight [14].
The identification of the FAMEs was carried out by
GLC using a capillary column of Polyethylene Glycol
(30 m × 320 μm×0 . 5 0μm) (Phenomenex, Inc. U.S.A)
using a Claurus 500 Perkin Elmers with an FID detector.
FAME was identified by comparison of retention times
with the corresponding commercial standards (Nu-Chek
Prep, Inc. MN, U.S.A) [14].
LOXs and COXs Enzyme Activities in Tumours
The activities of 12-LOX, 15-LOX-2 and COX-2 with
AA as the substrate and 15-LOX-1 with LA as the sub-
strate were estimated as described previously by Kelav-
kar UP et al, with slight modifications [15]. Briefly,
tumour cell (TC) suspensions (1 × 10
7 TC/ml) were
prepared from primary tumour that is free of necrotic
areas, blood clots and connective tissue, with 0.01% pro-
nase and 0.24% Type1-deoxyribonuclease in DMEM
(Sigma-Aldrich, St. Louis, MO, USA) and were washed
twice and resuspended in Ca
2+ and Mg
2+ free phosphate
buffer saline (PBS) and stimulated with ionophore
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15 min at 37°C. The metabolites were extracted using a
STRATA C-18 cartridge (1 ml) (Phenomenex, Inc. U.S.
A) and detected by Reverse-phase high performance
liquid chromatography (HPLC). Analysis were con-
ducted with a C18 Phenosphere-Next column (5 μm;
4.6 × 250 mm); (Phenomenex, Inc. U.S.A) equipped
with a Beckman System Gold Programmable Module
Model 126. Metabolic separation was achieved using a
time program. A linear gradient from solvent A: metha-
nol: water: acetic acid, 50:50:0.02 (v/v), pH 6 to solvent
B: methanol, over 20 min. UV Programmable Detector
Beckman System Gold Model 166 linked with a compu-
ter for data processing. UV analysis absorbance of the
eicosanoid PGE2 was at 196 nm, and 12(S)-HHT, 12(S)-
HETE, 15(S)-HETE and 13(S)-HODE was at 235 nm.
Quantifications of eicosanoids PGE2, and 12(S)-HHT
from COX-2 activity, and 12(S)-HETE, (12-LOX); 15(S)-
HETE (15-LOX-2) and 13(S)-HODE (15-LOX-1) were
obtained by using standard curves (Biomol International
LP Plymouth Meeting, U.S.A) and expressed as (ng/1 ×
10
7 TC) [16,17].
Evaluation of Apoptosis and mitosis
Apoptosis of TC was analyzed by flow cytometry (FC)
(Coulter® XL EPICS® Flow Cytometer), using an Annexin
V- Fitc apoptosis detection kit (Sigma-Aldrich, St. Louis,
MO, USA). The procedure is based on the binding
properties of conjugated Annexin V-Fitc to plasma
membrane phosphatidylserine (PS) in combination with
propidium iodide (PI) staining [18]. A complementary
approach to evaluate the same parameters was per-
formed by counting the apoptotic and mitotic figures in
slides of tumour tissue of 10 animals for each dietary
condition per 10 high-power fields scored descriptively
or semiquantitatively in a blinded manner [12].
Tumour leukocyte infiltration index
This study was assayed using CD3 complex expressed
on mature T lymphocytes and NK-T cells in tumour tis-
sue sections (4 μm) as the markers. The cells were
washed with PBS and incubated with the CD3
monoclonal hamster antimouse antibody (1:100 PBS)
(BD Biosciences Pharmingen, Philadelphia, U.S.A),
Immunoreactivity was revealed using an avidin-biotin-
peroxidase technique (Vectastain Elite ABC kit; Vector
Laboratories, Burlingame U.S.A). Infiltrating leukocytes
positive for CD3 were counted in high power fields at ×
400 and expressed as cells per unit area ± SEM
(n [microscopic fields per section] = 10 [19].
Statistical analysis
Data obtained were analyzed using the ANOVA Test,
and a generalized linear model with random component
gamma, canonic link function (covariates) was used to
evaluate the significance for diets, apoptosis, mitosis,
eicosanoids, tumour leukocyte infiltration, tumour
volume and metastases [20].
Results
Tumour cell membrane Fatty Acid Analyses
The levels of AA found in TC membranes isolated from
Peanut group was significantly higher (14.96%) than
Walnut (3.15%) and Control (1.72%) (p < 0.05). Never-
theless, LA content found in Walnut TC membranes
was higher (8.88%) than those measured in TC mem-
branes from Peanut (8.22%) and Control (6.31%) groups
(Fig 1 and Table 2).
The percentage ω-3 PUFAs in Peanut TC membranes
was lower (1.13%) in comparison to Walnut (4.90%) and
Control (5.26).
T h ed e g r e eo fm e m b r a n eF Au n s a t u r a t i o n( D B I / S )o f
Peanut TC membranes was significantly higher (2.50)
than Walnut (1.50) and Control (1.27) dietary treatment
(Table 2).
Effect of Diets on Tumour growth, Metastasis
development and Animal Survival
Tumour volume from Peanut and Walnut group was
lower (13.23 ± 1.24 cm
3 and 13.39 ± 1.08 cm
3, respec-
tively) than Control group (22.59 ± 1.6 cm
3)( p<0 . 0 5 )
(Figure 2-a). The number of metastases was lower in
Peanut group (2.47 ± 0.67) than in Walnut (4.44 ± 1.05)
Table 1 Fatty acids composition of Commercial diet, Walnut and Peanut oils. Fatty acids were determined as indicated
in Methods section.
Diet Saturated Fatty Acids Unsaturated Fatty Acids
ω-7 ω-9 ω-6 ω-3 DBI/S
14:0 16:0 18:0 20:0 22:0 24:0 16:1 18:1 20:1 22:1 18.2 18:3
Control 0.65 18.41 5.78 0.0 0.0 0.0 3.00 33.27 0.0 0.0 36.54 2.34 4.68
Walnut 0.0 7.21 2.29 0.08 0.0 0.0 0.07 22.04 0.07 0.0 51.08 17.15 18.35
Peanut 0.0 9.34 1.20 0.65 2.23 1.18 0.0 43.56 2.62 0.46 38.45 0.30 8.92
Values are the average of at least three determinations (SEM was less than 6% in all cases). The degree of membrane FA unsaturation is expressed as DBI/S
which means the sum of % each fatty acid × number of double bonds/% of saturated fatty acids.
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mice fed with Control diet B) or basic diet enrichment with Walnut oil C) or Peanut oil D).
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and were mainly located in lung, peritoneum and liver.
Furthermore, mice from Peanut and Walnut groups
showed the highest survival time (60 ± 4.92 and 52 ±
3.76 days after inoculum, respectively) compared to
Control (38 ± 4.62 days) (p < 0.05) (Figure 2-c).
Effects of Diets on tumour cell proliferation and
apoptosis
As shown in Figure3 a and Figure 3b, TC from Peanut
group showed significantly higher percentage of apopto-
tic cells (32.74 ± 5.99%) compared to Walnut (25.32 ±
6.12%) and Control groups (20.77 ± 4.27%) (p < 0.05).
Table 2 Fatty acid profile of TC membranes from host bearing M3 adenocarcinoma fed on different diets.
Diet Saturated Fatty acids Unsaturated Fatty Acid
ω-7 ω-9 ω-6 ω-3 DBI/S
14:0 16:0 18:0 22:0 24:0 16:1 18:1 20:1 22:1 18:2 20:2 20:4 20:3 20:5 22:5
Control 1.70 29:0 21.62 3.00 2.03 2.50 20.5 3.57 1.49 6.31 1.30 1.72 1.13 1.55 2.58 1.27
Walnut 1.50 27.35 21.66 1.83 2.80 1.65 21.45 1.92 1.16 8.88 1.75. 3.15 0.0 0.85 4.05 1.50
Peanut 0.92 23.70 18.14 1.66 0.77 2.79 22.60 2.09 0.71 8.33 2..21 14.96 0.0 0.00 1.13 2.50
Fatty acids composition of TC membrane was determined as indicate in Methods section. Values represent the mean in percentage of at least three
determinations from TC suspensions of 10
8 cells/ml (SEM was less than 6% in all cases). The degree of membrane FA unsaturation expressed as DBI/S: sum of %
each fatty acid × number of double bonds/% of saturated fatty acids.
Figure 2 Different parameters of tumour development and metastasis from M3 hosts fed on Control, Walnut and Peanut diets.
Different letters represent significant differences (p < 0.05): a) Tumour volume recorded during necropsy at 35 days after inoculation. Used as
volume = tumour height × width × height. Values represent the mean ± SEM of 18 samples. b) Metastasis number of M3 host fed on diets.
Values represent the mean ± SEM of 18 samples. c) Survival evaluation of M3 hosts fed on Control, Walnut and Peanut diets. Values represent
the mean ± SEM of 10 animals. Different letters represent significant differences (p < 0.05).
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Page 5 of 11Figure 3 a) Apoptotic cells in tumor cell suspension as determined by Flow cytometry using Annexin V/Propidium iodide double
staining. Values represent the mean ±SEM of six samples. Different letters represent significant differences (p<0.05).b) Flow cytometry graphics
show the apoptotic cells populations in tumor cells suspensions in the different diet conditions (circle areas). c) Mitotic and d) apoptotic figures
(arrows) on neoplastic tumor tissue fixed in 10% neutral formalin, dehydrated and embedded in paraffin and stained with hematoxylin and eosin
(arrows, H&E, 400 ×).
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recorded in tumour tissue: 2.03 ± 0.14/field; 1.40 ± 0.12/
field and 1.16 ± 0.12/field in Peanut, Walnut and Con-
trol, respectively (p < 0.05) (Table 3). Moreover, the
mitotic figures were inversely related to apoptotic
values. We observed lowest mitosis values (1.56 ± 0.36/
field) in Peanut group tumour tissue compared to Wal-
nut and Control groups (2.62 ± 0.30 and 3.3 ± 0.25/
field, respectively) (p < 0.05) (Table 3).
Modulation of LOX and COX Enzymes of the ω-6
Pathway in tumour cells
PUFAs of ω-6, ω-3 and ω-9 series modulated the for-
mation and release of COX and LOX products of ω-6-
AA and LOX products formed from w-6 LA after
tumor cell stimulation with the ionophore A 23187 as
s h o w ni nF i g u r e s4 .C O X - d e r i v e d - 1 2 ( S ) - H H Tw a ss i g -
nificantly higher in Peanut group (50.33 ng) than Wal-
nut (21.26 ng) and Control (23.12 ng) (Figure 4-a) (p <
0.05). On the other hand, PGE2,d e r i v e df r o mt h e
action of COX-2, released from the tumor cells of Con-
trol group were higher (1169.74 ng) compared with
Peanut (799.40 ng) and Walnut (807.45 ng) groups
(Figure 4-b), while tumor cells from the Peanut group
released significantly lower levels LOX-derived AA
eicosanoids: 12(S)-HETE (9.31 ng) and 15(S)-HETE
(8.88 ng) compared with those released by tumor cells
from Walnut (9.81 ng; 9.07 ng (p < 0.05) and Control
groups (10.35 ng; 9.16 ng, respectively (p < 0.05) (Fig.
4-c and Figure 4d). 13 (S)-HODE product derived from
LA by the action of LOX formed by the tumor cells of
Peanut group was significantly lower (10.51 ng) com-
pared to those formed from Walnut (10.90 ng) group.
Though 13(S)-HODE formed by the tumor cells of the
control group was higher compared to the Peanut
group it was not significantly different (Figure 4e)
Nevertheless, 13(S)-HODE/12(S)-HETE ratio was sig-
nificantly higher in Peanut group (1.13) compared with
b o t hW a l n u t( 1 . 1 1 )a n dC o n t r o l( 1 . 0 4 )g r o u p s( p<
0.05) (Figure 4-f).
Effect of ω-6, ω-3 and ω-9 dietary PUFAs on Tumour
leukocyte infiltration index
In order to know whether different oils could signifi-
cantly influence tumor infiltrating leukocyte number,
the number of lymphocyte T and NK-T cells in the
tumor tissue was analyzed by CD3 inmunolabeling in
tumour tissue sections (Table 4). The Peanut oil treated
group showed the lowest leukocyte infiltration index
(3.03 ± 1.05%) with respect to Walnut (16.71 ± 4.66%)
and Control (29.23 ± 4.90%) (p < 0.05) (Table 4).
Discussion
Epigenetic factors have emerged as key mechanisms in
cancer development. Of all the environmental factors,
diet plays a critical role in the prevention and pathobiol-
ogy of cancer [21]. In the present, we evaluated whether
post-weaning diet of mice modulates LOXs and COXs
activities through the eicosanoid release and their impact
on certain parameters related to a mammary gland ade-
nocarcinoma development. The comparative analysis of
the three dietary conditions showed that mice fed on
similar supplemented ω-6 fatty acids diets differing in
ω-9 and ω-3 content showed that ω-9 enriched Peanut
oil diet exhibited a protective effect on tumour develop-
ment in comparison to the other dietary oil treatments.
It was noted that Peanut oil group showed the lowest
number of mitosis, the highest amount of apoptosis,
decreased leukocyte infiltration and increased survival
time (Table 3 and Table 4; Figure 2 and Figure 3).
Unexpectedly, as shown in Table 2, Peanut oil treated
tumor cell membranes exhibited the highest ω-6 AA
levels compared to Walnut and Control (25.50 vs.1 3 . 7 8
and 9.33 respectively) groups despite the fact that
(Table 1) these oils do not contain any AA, while LA
content of Walnut oil is the highest of the three oils
used in the study (see Table 1). It is also surprising to
note that even though the Walnut treated tumor cell
membranes contained significantly higher amounts of
22:5 ω-3 fatty acid, the tumor volume and metastasis
number were higher, survival of animals bearing the
tumors was lower, and tumor cell apoptosis was less
and tumor cell mitotic numbers were higher in this
group compared to the Peanut oil treated group. These
results suggest that presence of higher amounts of ω-6
AA in the tumor cell membrane is responsible for the
beneficial effects seen.
It is known that dietary ω-6 LA is converted to AA by
the action of Δ6a n dΔ5 desaturases and the correspond-
ing elongases. It is likely that the high levels of AA noted
in Peanut group may be linked to the up-regulation of
Δ6 and Δ5 desaturases [21] that could explain the higher
levels of unsaturated fatty acids in the tumor cell
Table 3 Number of apoptosis and mitosis recorded in




Control 3.3 ± 0.26
A 1.16 ± 0.12
A
Walnut 2.62 ± 0.30
A 1.40 ± 0.12
A
Peanut 1.56 ± 0.36
B 2.03 ± 0.14
B
Values represent the mean ± SEM of apoptotic and mitotic figures counted
from 10 animals of each dietary condition (10 high-power fields). Different
letters represent significant differences (p < 0.05).
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Page 7 of 11Figure 4 Different eicosanoids released from M3 TC of hosts fed on different diets after stimulation with ionophore A 23287 (2 M).
Values represent the means ± SEM of 15 samples. Different letters represent significant differences (p < 0.05): a) 12 (S)-HHT; b) PGE2;
c) 12 (S)-HETE; d) 15 (S)-HETE; e) 13 (S)-HODE and f) 13 (S)-HODE/12 (S)-HETE ratio.
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forms substrate to COXs and LOXs enzymes and some
of their metabolites are: 12(S)-HHT and PGE2 via COXs;
12(S)-HETE and 15(S)-HETE via LOXs, while LA is a
substrate for 15-LOX-1 and 13-HODE is its major meta-
bolite. In the Peanut group, we observed the highest level
of 12(S)-HHT, a lipoperoxide marker, and lower levels of
PGE2 compared to control group. Both 12(S)-HHT and
PGE2 are products of the activity of COX enzymes,
whereas only PGE2 is formed due to the activity of the
specific enzyme PGE synthase that explains changes in
the levels of various eicosanoids in the cells. It has been
shown that enhanced formation of lipid peroxides and
low PGE2 production inhibit cancer progression and
tumour growth [24]. Moreover, the lower percentage of
tumour leukocyte infiltration exhibited in Peanut group
(Table 4) correlated well with the low PGE2 levels
observed, which is considered as an activator of inflam-
matory process and related to pro-carcinogenic events
[25]. There is evidence to suggest that tumor infiltrating
macrophages enhance tumor growth, promote tumor cell
motility and angiogenesis [26,27]. Though the exact
mechanism(s) by which tumor-infiltrating macrophages
enhance tumor growth is not clear, it is possible that
these macrophages produce excess of PGE2,T N F - a and
other pro-inflammatory molecules that aid tumor cell
growth. PGE2 is derived from AA, while TNF-a enhances
PGE2 production [28]. On the other hand, PGE2 sup-
presses TNF-a production [29-32]. Inhibition of PGE2
synthesis was found to enhance TNF-a production and
augment macrophage tumoricidal activity [29,31]. In con-
trast, phospholipase A2 activity and AA was reported to
be essential for the tumoricidal action of TNF-a [33-36].
It is known that both ω-3 and ω-6 fatty acids inhibit the
production of TNF-a [37-39]. Thus, the relationship
among PUFAs, eicosanoids and TNF-a and their actions
on tumor cells is complex. In this complex net work of
events, in general, PGE2 serves as an immunosuppressor
and inhibits the tumoricidal action of macrophages;
TNF-a needs phospholipase A2 activity and free AA to
bring about its anti-tumor action; while free AA and
other PUFAs have direct tumoricidal action [28-41].
In the present study, we found that 12(S)-HETE
levels were significantly lower, higher degree of apop-
tosis of tumor cells and lowest rate of mitosis counts
i nt h e( F i g u r e4a n dT a b l e3 )P e a n u to i lg r o u ps u g g e s t -
ing that inhibition of 12(S)-HETE production
diminishes cell proliferation and induces apoptosis as
previously described [42]. Coincidently, high level of
12(S)-HHT could be related to increased apoptosis.
These results are in agreement with previous studies
that showed that lipid peroxides are selectively toxic to
tumour cells by triggering apoptosis through nuclear
caspase activation [43,44]. Indeed, oxidation is the
initial mechanism for inducing the phosphatidyl-serine
translocation from the cytosol domain to the external
membrane, considered to be a key step in the apopto-
tic process [45]. Thus, lower tumor cell proliferation
and enhanced apoptosis could have resulted in reduced
tumour volume (Figure 2 and Figure 3). With respect
to 15-LOX-1 activity, Peanut group showed signifi-
cantly low levels of its major metabolite, 13-HODE.
Also, this group exhibited the lowest metastasis num-
ber (Figure 2b). Although 13-HODE levels were lower
in Peanut group, 13-HODE/12-HETE ratio was signifi-
c a n t l yh i g h e r( 1 . 1 3 )t h a nW a l n u t( 1 . 1 1 )a n dC o n t r o l
(1.04) groups (Figure 4f). Previously, we showed that
13-HODE has anti-metastatic action, while 12(S)-
HETE enhances metastasis [17]. In addition, it was
observed that mammary gland tumour cells from mice
fed with ω-6 enriched diet released higher levels of 12
(S)-HETE which could be linked to the high number
of metastasis in this animal model [12]. Several others
showed that 12(S)-HETE is produced in large amounts
by various epithelial cancer cell lines that positively
correlated to their metastatic potential [46]. The lower
amounts of 15(S)-HETE noted in Peanut oil fed tumor
cell group could be attributed to its anti-tumour action
lending support to the previous evidence that this
metabolite is present in low concentrations in different
tumour tissues [47].
In summary, the present study showed that diets
enriched with high levels of ω-9 fatty acids reduce
tumour growth, metastasis and tumor leukocyte infil-
tration by: 1) inhibiting LOXs activity, reducing the
formation of pro-tumorigenic eicosanoids such as 12
(S)-HETE and 15 (S)-HETE, 2) increasing the synthesis
of 12 (S)-HHT that induces apoptosis and 3) decreas-
ing the production of pro-inflammatory PGE2.U n d e r -
standing the mechanisms by which ω-3, ω-6 and ω-9
PUFAs alter growth and trigger apoptosis of breast
cancer cells is essential to devise newer dietary thera-
peutic strategies to prevent cancer and employ various
fatty acid rich oils to potentiate the actions of the cur-
rent anti-cancer therapies.
Table 4 Percentage of positive immunolabeling for CD3-
T-lymphocytes and NK-T cells infiltration in tumor tissue.
Diets % of Tumor Infiltration
Control 29.23 ± 4.90
A
Walnut 16.71 ± 4.66
A
Peanut 3.03 ± 1.05
B
The values indicate immunolabeling and represent the mean ± SEM of gold-
silver particles showing positive labeling of CD3 in 15 fields evaluated in 10
tumor sections of each dietary treatment. Different letters represent
significant differences (p < 0.05).
Comba et al. Lipids in Health and Disease 2010, 9:112
http://www.lipidworld.com/content/9/1/112
Page 9 of 11Acknowledgements
We are indebted to Mr. Ricardo Mattos for animal care. We are grateful to
Dr. Constancio Giraudo for technical assistance in flow cytometry at the
Fundación para el Progreso de la Medicina de la Ciudad de Córdoba-
Argentina. Dr. U.N. Das is in receipt of Ramalingaswami fellowship of the
Department of Biotechnology, India during the tenure of this study. This
work was supported, in part, under the bilateral cooperation project
between governments of India and Argentina (DST- MINCYT), ARG-RPO
033/2006). This work was supported by Grants from FONCYT, Ministerio de
Ciencia y Técnica de la Provincia de Córdoba- Argentina, CONICET-
Argentina and SECYT-UNC.
Author details
1Cátedra de Biología Celular, Histología y Embriología, Instituto de Biología
Celular, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba.
Argentina.
2Instituto Multidisciplinario de Biología Vegetal (IMBIV-CONICET),
Cátedra de Química Orgánica, FCEF y N. Universidad Nacional de Córdoba,
Argentina.
3Consejo Nacional de Investigaciones Científicas y Técnicas
(CONICET), Avenida Rivadavia 1917 - CP C1033AAJ - Qty. Buenos Aires,
Argentina.
4Jawaharlal Nehru Technological University, Kakinada 533 003,
India.
5UND Life Sciences, 13800 Fairhill Road, #321, Shaker Heights, OH
44120, USA.
6Krishna Institute of Medical Sciences, Secunderabad-500 003,
India.
Authors’ contributions
ARE and MEP conceived the study, participated in its design and
coordination; AC, DMM, MAB and CPG performed various experiments; ARE,
MEP and UND interpreted the data and wrote the manuscript; all authors
read and approved the final manuscript
Competing interests
The authors declare that they have no competing interests.
Received: 24 September 2010 Accepted: 8 October 2010
Published: 8 October 2010
References
1. International Agency for Research on Cancer. Globocan 2008, Lyon 2008
[http://www-dep.iarc.fr/].
2. Bidgoli SA, Ahmadi R, Zavarhei MD: Role of hormonal and environmental
factors on early incidence of breast cancer in Iran. Scie Total Enviorn 2010,
408:4056-4061.
3. Thiébaut AC, Chajès V, Gerber M, Boutron-Ruault MC, Joulin V, Lenoir G,
Berrino F, Riboli E, Bénichou J, Clavel-Chapelon F: Dietary intakes of
omega-6 and omega-3 polyunsaturated fatty acids and the risk of
breast cancer. Int J Cancer 2009, 124:924-931.
4. Shaikh IA, Brown I, Wahle KW, Heys SD: Enhancing cytotoxic therapies for
breast and prostate cancers with polyunsaturated fatty acids. Nutr
Cancer 2010, 62:284-96.
5. Hyde CAC, Missailidis S: Inhibition of arachidonic acid metabolism and its
implication on cell proliferation and tumour-angiogenesis. Intern
Immunoph 2009, 9:701-715.
6. Comba A, Pasqualini ME: Primers on Molecular Pathways - Lipoxygenases:
Their Role as an Oncogenic Pathway in Pancreatic Cancer. Pancreatology
2009, 9:724-728.
7. Moreno JJ: New aspects of the role of hydroxyeicosatetraenoic acids in
cell growth and cancer development. Biochem Pharmacol 2009, 77:1-10.
8. Das UN: Influence of polyunsaturated fatty acids and their metabolites
on stem cell biology. Nutrition .
9. Zeidler R, Csanady M, Gires O, Lang S, Schmitt B, Wollenberg B: Tumour
cell-derived prostaglandin E2 inhibits monocyte function by interfering
with CCR5 and Mac-1. FASEB J 2000, 17:661-668.
10. Tobares L, Guzmán C, Maestri DM: Effect of the Extraction and Bleaching-
Processes on Jojoba (Simmondsia chinensis) Wax Quality. Eur J Lipid Sci
Technol 2003, 105:749-753.
11. Galli S, Labato MI, Bal de Kier Joffé E, Carreras MC, Poderoso JJ: Decreased
mitochondrial nitric oxide synthase activity and hydrogen peroxide
relate persistent tumoral proliferation to embryonic behavior. Cancer Res
2003, 63:6370-6377.
12. Espada CE, Berra MA, Martinez MJ, Eynard AR, Pasqualini ME: Effect of Chia
Oil (Salvia Hispanica) rich in n-3 fatty acids on the eicosanoid release,
apoptosis and T-lymphocyte tumour infiltration in a murine mammary
gland. Prost Leukot Essent Fatty Acids 2007, 77:21-28.
13. Maestri DM, Guzmán CA: A comparative study of seed lipid components
of Nicotianeae (Solanaceae). Biochem Syst Ecl 1995, 23:201-207.
14. Calderón RO, Eynard AR: Fatty acids specifically related to the anisotropic
properties of plasma membrane from rat urothelium. Biochim Biophys
Acta 2000, 1483:174-84.
15. Kelavkar UP, Hutzley J, Mc Hugh K, Allen KGD, Parwani A: Prostate tumour
growth can be modulated by dietary targeting the 15-lipoxygenase- I
and cyclooxygenase-2 enzymes. Neoplasia 2009, 11:692-699.
16. Pasqualini ME, Mohn CE, Petiti JP, Eynard AR: COX and LOX eicosanoids
modulate platelet activation and procoagulation induced by two murine
cancer cells. Prost Leukot Essent Fatty Acids 2000, 63:377-383.
17. Pasqualini ME, Heyd VL, Manzo P, Eynard AR: Association between E-
cadherin expression by human colon, bladder and breast cancer cells
and the 13-HODE: 15-HETE ratio. A possible role of their metastatic
potential. Prost Leukot Essent Fatty Acids 2003, 68:9-16.
18. Vermmes C, Haanen CP, Reutelingsperger M: A novel assay for apoptosis:
flow cytometric detection of phosphatidylserine expression on early
apoptotic cells using fluorescein labelled annexin V. J Immunol Methods
1995, 180:38-52.
19. Maruoka H, Shinohara K, Miyata M, Sugimura T, Terada M, Wakasugi H:
A novel monoclonal antibody permitting recognition of NKT cells in
various mouse strains. Biochem Biophys Res Commun 1998, 242:413-418.
20. In-Kwon Y: Generalized weighted additive models based on distribution
functions. Statis Probab Lett 2007, 77:1394-1402.
21. Das UN: Essential Fatty acids a review. Curr Pharm Biotechnol 2006, 7:467-82.
22. Das UN: Can essential fatty acids reduce the burden of disease(s)? Lipids
Health Dis 2008, 7:9-27.
23. Tapiero H, Ba GN, Coureur P, Tew KD: Polyunsaturated fatty acids (PUFAs)
and eicosanoids in human health and pathologies. Biomed Pharmacol
2000, 56:215-222.
24. Pair R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS:
Prostagalndin E2 transactivates EGF receptor: a novel mechanism for
promoting colon cancer growth and gastrointestinal hypertrophy. Nat
Med 2002, 8:289-293.
25. Wang D, Dubois RN: The role of COX-2 in intestinal inflammation and
colorectal cancer. Oncogene 2010, 29:781-788.
26. Ruhrberg C, De Palma M: Deciphering macrophage roles in human
tumors. Nat Med 2010, 16:861-862.
27. Qualls JE, Murray PJ: Stopping macrophages wounds tumors. Nat Med
2010, 16:863-864.
28. Tashjian AH Jr, Voelkel EF, Lazzaro M, Goad D, Bosma T, Levine L: Tumor
necrosis factor-alpha (cachectin) stimulates bone resorption in mouse
calvaria via a prostaglandin-mediated mechanism. Endocrinology 1987,
120:2029-2036.
29. Alleva DG, Burger CJ, Elgert KD: Tumor growth increases Ia- macrophage
synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes
in macrophage suppressor activity. J Leukoc Biol 1993, 53:550-558.
30. Karck U, Peters T, Decker K: The release of tumor necrosis factor from
endotoxin-stimulated rat Kupffer cells is regulated by prostaglandin E2
and dexamethasone. J Hepatol 1988, 7:352-361.
31. Ben-Efraim S, Bonta IL: Modulation of antitumour activity of macrophages
by regulation of eicosanoids and cytokine production. Int J
Immunopharmacol 1994, 16:397-399.
32. Chae BS, Shin TY, Kim DK, Eun JS, Leem JY, Yang JH: Prostaglandin E2-
mediated dysregulation of proinflammatory cytokine production in
pristane-induced lupus mice. Arch Pharm Res 2008, 31:503-510.
33. Palombella VJ, Vilcek J: Mitogenic and cytotoxic actions of tumor necrosis
factor in BALB/c 3T3 cells. Role of phospholipase activation. J Biol Chem
1989, 264:18128-18136.
34. Suffys P, Beyaert R, Van Roy F, Fiers W: Reduced tumour necrosis factor-
induced cytotoxicity by inhibitors of the arachidonic acid metabolism.
Biochem Biophys Res Commun 1987, 149:735-743.
35. Suffys P, Beyaert R, De Valck D, Vanhaesebroeck B, Van Roy F, Fiers W:
Tumour-necrosis-factor-mediated cytotoxicity is correlated with
phospholipase-A2 activity, but not with arachidonic acid release per se.
Eur J Biochem 1991, 195:465-475.
36. Neale ML, Fiera RA, Matthews N: Involvement of phospholipase A2
activation in tumour cell killing by tumour necrosis factor. Immunology
1988, 64:81-85.
Comba et al. Lipids in Health and Disease 2010, 9:112
http://www.lipidworld.com/content/9/1/112
Page 10 of 1137. Watanabe S, Onozaki K, Yamamoto S, Okuyama H: Regulation by dietary
essential fatty acid balance of tumor necrosis factor production in
mouse macrophages. J Leukoc Biol 1993, 53:151-156.
38. Tappia PS, Man WJ, Grimble RF: Influence of unsaturated fatty acids on
the production of tumour necrosis factor and interleukin-6 by rat
peritoneal macrophages. Mol Cell Biochem 1995, 143:89-98.
39. Kumar GS, Das UN: Effect of prostaglandins and their precursors on the
proliferation of human lymphocytes and their secretion of tumor
necrosis factor and various interleukins. Prostaglandins Leukot Essent Fatty
Acids 1994, 50:331-334.
40. Das UN: Tumoricidal action of cis-unsaturated fatty acids and their
relationship to free radicals and lipid peroxidation. Cancer Lett 1991,
56:235-243.
41. Das UN, Prasad VV, Reddy DR: Local application of gamma-linolenic acid
in the treatment of human gliomas. Cancer Lett 1995, 94:147-155.
42. Nazarewicz RR, Zenebe WJ, Parihar A, Parihar MS, Vaccaro M, Rink C,
Sen CK, Ghafourifar P: 12(S)-hydroperoxyeicosatetraenoic acid (12-HETE)
increases mitochondrial nitric oxide by increasing intramitochondrial
calcium. Arch Biochem Biophys 2007, 468:114-20.
43. Das UN: Essential fatty acids, lipid peroxidation and apoptosis.
Prostaglandins Leukot Essen Fatty Acids 1999, 61:157-63.
44. Uauy R, Solomons N: Diet, Nutrition, and the life-course approach to
cancer prevention. J Nutr 2005, 135:2934S-2945S.
45. Zuo X, Wu Y, Morris JS, Stimmel JB, Leesnitzer LM, Fischer SM, Lippman SM,
Shureiqi I: Oxidative metabolism of linoleic acid modulates PPAR-beta/
delta suppression of PPAR-gamma activity. Oncogene 2006, 25:1225-1241.
46. Nie D, Krishnamoorthy S, Jin R, Tang K, Chen Y, Qiao Y, Zacharek A, Guo Y,
Milanini J, Pages G, Honn KV: Mechanisms regulating tumour
angiogenesis by 12-lipoxygenase in prostate cancer cells. J Biol Chem
2006, 281:18601-18609.
47. Srivastava K, Kundumani-Sridharan V, Zhang B, Bajpai AK, Rao GN: 15(S)-
Hydroxyeicosatetraenoic Acid-Induced Angiogenesis Requires STAT3-
Dependent Expression of VEGF. Cancer Res 2007, 67:4328-4336.
doi:10.1186/1476-511X-9-112
Cite this article as: Comba et al.: Effect of ωω-3 and ωω-9 fatty acid rich
oils on lipoxygenases and cyclooxygenases enzymes and on the
growth of a mammary adenocarcinoma model. Lipids in Health and
Disease 2010 9:112.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Comba et al. Lipids in Health and Disease 2010, 9:112
http://www.lipidworld.com/content/9/1/112
Page 11 of 11